Basel Medical Group Ltd (BMGL)
NASDAQ: BMGL · Real-Time Price · USD
5.00
+0.12 (2.46%)
At close: Apr 1, 2025, 4:00 PM
5.18
+0.18 (3.60%)
After-hours: Apr 1, 2025, 6:41 PM EDT

Basel Medical Group Cash Flow Statement

Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Jun '24 Jun '23 Jun '22
Net Income
2.071.781.98
Depreciation & Amortization
0.530.560.58
Asset Writedown & Restructuring Costs
-0.05-
Provision & Write-off of Bad Debts
-0.010.160.03
Other Operating Activities
-0.08-0.230.13
Change in Accounts Receivable
-0.420.540.01
Change in Inventory
0.02-0.020
Change in Accounts Payable
0.39-0.220.06
Operating Cash Flow
2.512.62.79
Operating Cash Flow Growth
-3.49%-6.89%-
Capital Expenditures
-0.01-0.01-0.09
Investing Cash Flow
-0.01-0.01-0.09
Short-Term Debt Issued
1.42--
Long-Term Debt Issued
--1.03
Total Debt Issued
1.42-1.03
Short-Term Debt Repaid
---10.86
Long-Term Debt Repaid
-2.92-2.94-3.09
Total Debt Repaid
-2.92-2.94-13.95
Net Debt Issued (Repaid)
-1.5-2.94-12.92
Other Financing Activities
-0.270-
Financing Cash Flow
-1.77-2.94-12.92
Net Cash Flow
0.73-0.35-10.22
Free Cash Flow
2.52.592.7
Free Cash Flow Growth
-3.56%-4.07%-
Free Cash Flow Margin
24.84%26.61%25.37%
Free Cash Flow Per Share
0.150.160.17
Cash Interest Paid
0.180.240.32
Cash Income Tax Paid
0.410.290.03
Levered Free Cash Flow
1.431.89-
Unlevered Free Cash Flow
1.542.04-
Change in Net Working Capital
0.32-0.24-
Updated Nov 4, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q